Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
26 Results for "
PSA protein
" in MedChemExpress (MCE) Product Catalog:
Products (26)
26 Results for "PSA protein" in MCE Product Catalog:
2
2 Cited Publications
Cat. No.: HY-N7045
CAS No.: 142796-22-3
Category:
Cyamopsis tetragonoloba (L.) Taub. Plants Compositae Flavanonols Glycine soya Flavonoids Phenols Polyphenols Disease Research Fields Cancer
Target:
1
1 Cited Publications
Cat. No.: HY-P70606A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KLK3; Kallikrein 3, (Prostate Specific Antigen), Isoform CRA_e; Prev. APS; Kallikrein 3, (Prostate Specific Antigen), Isoform CRA_d; PSA; Kallikrein 3, (Prostate Specific Antigen), Isoform CRA_f; Prostate Specific Antigen; Kallikrein 3, (Prostate Specific
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P70266
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KLK3; Kallikrein 3, (Prostate Specific Antigen), Isoform CRA_e; Prev. APS; Kallikrein 3, (Prostate Specific Antigen), Isoform CRA_d; PSA; Kallikrein 3, (Prostate Specific Antigen), Isoform CRA_f; Prostate Specific Antigen; Kallikrein 3, (Prostate Specific
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P74614
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PROS1; PS25; Prev. PROS; Truncated protein S Alpha Variant; Vitamin K-Dependent protein S; Truncated protein S Alpha; protein S (Alpha); protein S Alpha Variant; protein Sa; PROS1 protein; PS21; THPH5; PS22; THPH6; PS23; PSA; PS24; protein S; Vitamin K-De
Species:
Human
Source:
HEK293
Target:
Research Areas:
ARD-69 is a PROTAC degrader based on the E3 ubiquitin ligase VHL and targeting the androgen receptor, which can induce androgen receptor (AR) protein degradation in AR-positive prostate cancer cells. ARD-69 inhibits AR-regulated gene expression, binds to the AR ligand binding domain at one end and binds to VHL at the other end, prompting AR to be recruited to the E3 ubiquitin ligase complex, triggering proteasome degradation, thereby inhibiting AR signaling pathways and downstream gene expression (such as PSA, TMPRSS2). ARD-69 can be used to study of castration-resistant prostate cancer (mCRPC) .
Cat. No.: HY-143332
CAS No.: 3033288-68-2
Target:
Research Areas:
TRIM24/BRPF1-IN-2 (compound 20l) is a potent TRIM24/BRPF1 dual inhibitor, with IC50 values of 0.98 and 1.16 μM, respectively. TRIM24/BRPF1-IN-2 shows TRIM24/BRPF1 bromodomain binding affinity. TRIM24/BRPF1-IN-2 can be used for prostate cancer research .
Cat. No.: HY-174391
CAS No.: 1790308-86-9
Target:
Research Areas:
AR antagonist 15 is an orally active androgen receptor (AR) antagonist with the IC50 of 97 nM for ART787A. AR antagonist 15 disrupts AR nuclear translocation, hinders AR homodimerization, and suppresses transcription of AR-regulated genes by competitive binding to the ligand binding pocket. AR antagonist 15 can significantly lower the prostate-specific antigen (PSA) level. AR antagonist 15 induces apoptosis by reducing the expression of apoptosis pathway related proteins. AR antagonist 15 can be used for the research of prostate cancer.
Cat. No.: HY-NP002N
Synonyms: Pigeon Serum Albumin
Cat. No.: HY-170820
CAS No.: 3006788-11-7
Target:
Molecular Glues Eukaryotic Release Factor (eRF) Bcl-2 Family CDK EGFR HSP Androgen Receptor c-Myc
Research Areas:
XYD049 is a CRBN-based molecular glue degrader targeting GSPT1, with a DC50 of 19 nM. XYD049 mediates the formation of a ternary complex between CRBN and GSPT1, thereby triggering CRBN- and proteasome-dependent degradation of GSPT1. By degrading GSPT1, XYD049 downregulates castration-resistant prostate cancer (CRPC)-related oncogenes, including BCL2, CDK2, E2F3, EGFR, HSP90B1, TMPRSS2, AR, AR-V7, PSA and c-Myc. XYD049 inhibits cancer cell growth and suppresses tumor growth in mice. XYD049 can be used for research on castration-resistant prostate cancer. XYD049 consists of a linker (black part) NH2-C5-NH-Boc (HY-W004710), a CRBN-based E3 ligase ligand (blue part) Thalidomide 4-fluoride (HY-41547), and a target protein ligand (red part) GSPT1 ligand-1 (HY-170821), among which the E3 ligase ligand plus linker forms the conjugate E3 Ligase Ligand-linker Conjugate 158 (HY-170822) .
Cat. No.: HY-173409
CAS No.: 3005979-40-5
Target:
Research Areas:
AR antagonist 11 (Compound c2) is a selective AR antagonist with an IC50 of 0.019 μM. AR antagonist 11 is also effective against AR F877L/T878A mutant (IC50: 1.03 μM). AR antagonist 11 inhibits LNCaP cell proliferation and reduces PSA protein expression (IC50: 0.54 μM). AR antagonist 11 can be used for research of prostate cancer (PCa) .
Cat. No.: HY-173559
CAS No.: 2902679-42-7
Target:
Research Areas:
AR antagonist 12 (compound 20i) is an orally active androgen receptor antagonist wiith IC50 values of 119.3 μM and 98.2 μM for wt-AR and AR-F877L,respectively. AR antagonist 12 induces a dose-dependent and time-dependent reduction in AR, AR-V7, and PSA protein levels. AR antagonist 1 shows anticancer activuty and can be used for the study of Enzalutamide (HY-70002)-resistant Prostate cancer .
Cat. No.: HY-N7045R
CAS No.: 142796-22-3
Cat. No.: HY-155666
CAS No.: 2952994-34-0
Research Areas:
YXG‑158 is an orally active, anticancer bifunctional steroid analog with both androgen receptor (AR) degradation activity (DC50 = 1.28 μM) and CYP17A1 inhibitory activity (IC50 = 100 nM). YXG-158 reduces AR protein and mRNA expression via proteasome-dependent degradation, degrades AR-V7, and inhibits CYP17A1 enzymatic activity to block androgen biosynthesis. YXG-158 inhibits the activities of ERα and ERβ, as well as cancer cell proliferation. YXG-158 decreases the weight of androgen-sensitive organs in castrated rats treated with testosterone propionate, downregulates AR protein, reduces PSA levels, and suppresses tumor growth in Enzalutamide (HY-70002)-sensitive and -resistant xenograft models. YXG-158 can be used in prostate cancer-related research .
Cat. No.: HY-183667
CAS No.: 1332390-06-3
Target:
Research Areas:
JNJ-pan-AR is an orally active androgen receptor (AR) inhibitor with an IC50 of 19 nM and a Ki of 8.4 nM against human wild-type AR. JNJ-pan-AR abolishes androgen-induced KLK2 and KLK3 mRNA expression and reduces androgen-dependent colony formation in prostate cancer cells. JNJ-pan-AR blocks AR nuclear translocation, inhibits PSA protein expression, and represses the growth of AR-dependent tumor cells and ARF877L-driven tumor xenografts. JNJ-pan-AR blocks transactivation and signaling of wild-type AR and various mutant AR variants. JNJ-pan-AR is applicable for research on castration-resistant prostate cancer .
Cat. No.: HY-P701351
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PSAT1; Phosphoserine Transaminase; Phosphoserine Aminotransferase 1; Endometrial Progesterone-Induced protein; PSAT; PSATD; PSA; NLS2; Phosphoserine Aminotransferase; EPIP; Phosphohydroxythreonine Aminotransferase
Species:
Human
Source:
E. coli
Cat. No.: HY-P78999
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PSAT1; Phosphoserine Transaminase; Phosphoserine Aminotransferase 1; Endometrial Progesterone-Induced protein; PSAT; PSATD; PSA; NLS2; Phosphoserine Aminotransferase; EPIP; Phosphohydroxythreonine Aminotransferase
Species:
Human
Source:
E. coli
Cat. No.: HY-P701352
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PSAT1; Phosphoserine Transaminase; Phosphoserine Aminotransferase 1; Endometrial Progesterone-Induced protein; PSAT; PSATD; PSA; NLS2; Phosphoserine Aminotransferase; EPIP; Phosphohydroxythreonine Aminotransferase
Species:
Human
Source:
E. coli
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
